Full-Time

Director Project Management

Oncology

Precision AQ

Precision AQ

501-1,000 employees

Data-driven drug access and launches

Compensation Overview

$162k - $243k/yr

+ Annual bonus

Remote in USA

Remote

Travel domestically and internationally, including overnight stays, is required.

Bachelor's

Category
Business & Strategy (1)
Required Skills
Microsoft Office
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to Precision AQ

See people who can refer or advise you

Requirements
  • A bachelor's degree or equivalent combination of education and experience in a science or health-related field is required.
  • At least 10 years of experience in clinical research, including extensive project management and line management experience or proven competencies for the position, is required.
  • Working knowledge of Good Clinical Practice and International Council for Harmonisation guidelines and the clinical development process is required.
  • Experience with Microsoft Office products, including Outlook, Word, Excel, and PowerPoint, and Microsoft Project is required.
  • Ability to travel domestically and internationally, including overnight stays, is required.
  • Working knowledge of project management techniques and tools is required.
  • Direct work experience in a global, cross-functional project management environment is required.
  • Proven experience in people management is required.
  • Proven experience in strategic planning, risk management, and change management is required.
  • Ability to work closely with business unit leadership to understand customer needs is required.
  • Strong analytical skills and business acumen are required.
  • Executive presence and the ability to confidently deliver complex presentations to senior management are required.
  • A demonstrated leadership track record and effective interpersonal skills are required.
  • Ability to lead and inspire excellence within a team is required.
  • Ability to create an environment where employees have a sense of ownership that increases productivity and efficiency is required.
  • Excellent time management, negotiation, critical thinking, decision-making, analytical, interpersonal, presentation, verbal, and written communication skills are required.
  • Proficiency in project management software is required.
  • In-depth proven experience in pharmaceutical and/or device research is required.
  • Proven planning and organizing skills are required.
  • Ability to influence and lead is required.
  • Proven experience delegating while fostering cohesive team dynamics is required.
  • Demonstrated successful independent negotiation and conflict-management strategies are required.
Responsibilities
  • Work cross-functionally to develop partnership strategies for clinical trials and programs.
  • Provide oversight and strategic expertise in the planning, coordination, and delivery of activities for designated clinical study projects to achieve quality, scope, cost, and time objectives.
  • Direct, manage, and ensure collaboration within a team of Project Directors and Project Managers in the planning, execution, and governance of global projects and portfolios.
  • Provide leadership and oversight on clinical programs and, in unique cases, manage activities directly.
  • Interact with study sponsors as the primary point of escalation beyond project management.
  • Optimize the profitability of the Project Management organization to meet or exceed budget targets.
  • Assess and manage resource allocations to meet established cost, time, and quality goals.
  • Select, train, develop, and manage the performance of Project Directors and Project Managers.
  • Provide technical support and guidance to assigned project managers, including scope definition, risk identification, escalation and mitigation, resource planning, goals, and deliverables.
  • Identify and escalate impacts to project scope, resources, schedule, or budget through standard methods.
  • Ensure project leadership personnel work to the highest quality standards and maintain compliance with established standard operating procedures, working guidelines, project plans, and regulatory requirements.
  • Participate with Business Development in opportunity development, proposals and budgeting, and bid defense preparation and attendance.
  • Manage project and program interdependencies to achieve program milestones and deliverables.
  • Conduct evaluations and implement required changes for projects, including recovery of at-risk projects, re-scoping, postponement, or cancellation.
  • Measure and report key performance indicators and lead continuous improvement.
  • Manage the workload of supervised staff with continued assessment and adjustment as needed.
  • Provide ongoing feedback, development, coaching, and annual performance reviews for Project Directors and Project Managers.
Desired Qualifications
  • An advanced degree is preferred.
  • Experience managing complex and global trials is preferred.

Precision AQ helps pharmaceutical companies get FDA-approved medicines to patients by using data, evidence, and market insights to shape access and launches. Its services combine medical science, commercial strategy, and technology development to create new pathways for drug availability and timely delivery. The company partners with drug makers to plan launches and expansion, using analytical and creative approaches to make medicines reachable and effective in real-world settings. Unlike firms that focus only on science or marketing, Precision AQ blends data-driven insights with strategic execution across development and commercialization to accelerate patient access. The goal is to raise standards in healthcare accessibility and impact by getting the right medicines to the right patients faster.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Get referred to Precision AQ

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Precision AQ says it serves all 30 top pharma companies and launched 450-plus drugs.
  • April 25, 2025 oncology hires sharpen payer, provider, and formulary strategy for launches.
  • May 28, 2026 ASCO materials showcase OncoGenius and Navigator365 Matrix with 100-plus cancer centers.

What critics are saying

  • IQVIA, ICON, and Syneos Health crowd Precision AQ’s commercialization niche globally.
  • AI patient-services commoditization from Phluence-style tools compresses consulting margins by 2027.
  • Reliance on pharma launch budgets creates existential exposure if one major client insources access strategy.

What makes Precision AQ unique

  • Precision AQ’s AET has 25-plus former access decision-makers, built since 2009.
  • February 17, 2026 hires Emma Hawe and Yahya Anvar deepen HEOR, AI, and EU reach.
  • November 18, 2025 Phluence investment extends agentic post-Rx automation beyond traditional HUB models.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Sick Leave

Parental Leave

Performance Bonus

Company News

PR Newswire
Feb 17th, 2026
Precision AQ expands leadership with AI and data strategy hires to strengthen global biopharma solutions

Precision AQ, a global life sciences commercialisation partner, has appointed two senior leaders to expand its AI and data capabilities. Emma Hawe joins as Senior Vice President, Managing Director for Evidence Synthesis & Decision Modelling, bringing over 25 years of experience in evidence generation and applied statistics. She currently chairs ISPOR's HEOR Excellence—Methodology Award. Yahya Shaikh becomes Senior Vice President, Data Strategy & AI, focusing on strengthening the company's data foundation and advancing AI-enabled solutions. He brings decades of experience in AI, analytics and enterprise data strategy across life sciences and healthcare. The appointments aim to bolster Precision AQ's presence in the EU whilst expanding its global reach. The company works with all 30 top pharmaceutical firms and has launched over 450 drugs across therapeutic areas.

StreetInsider
Nov 18th, 2025
Precision AQ Invests in Phluence Platform

Precision AQ has made a strategic investment in Phluence, enhancing its post-prescription capabilities. This investment allows pharmaceutical manufacturers to virtualize patient services, reduce costs, and improve access through Phluence's advanced agentic workflow management platform. The collaboration aims to modernize patient engagement with AI-driven solutions, offering an alternative to traditional HUB models. This move supports Precision AQ's goal to streamline patient services and accelerate access to therapies.

PR Newswire
Apr 25th, 2025
Precision Aq Expands Industry-Leading Access Experience Team (Aet) With Three Oncology Experts

-- Shraddha Kansagra, PharmD, BCOP, former Clinical Pharmacy Specialist at UT Southwestern, appointed Vice President, Clinical Oncology Solutions ---- Angelica Norrell, PharmD, BCOP, CSP, former Senior Director of Product at Optum, joins as Senior Director, AET ---- Courtney Patterson, PharmD, MBA, former System Director of Oncology Pharmacy Services at Advocate Health, joins as Vice President, Clinical Oncology Solutions --NEW YORK, April 25, 2025 /PRNewswire/ -- Precision AQ, a leader in life sciences commercialization and a driving force in expanding patient access to life-changing therapies, today announced the additions of Shraddha Kansagra, PharmD, BCOP, Angelica Norrell, PharmD, BCOP, CSP, and Courtney Patterson, PharmD, MBA to its Access Experience Team (AET). These experts join Precision AQ's AET, an industry-leading team of former access decision-makers and influencers, to provide critical insights to life science companies and support them in anticipating payer challenges and designing strategies to optimize patient access in oncology.As access decisions in oncology increasingly incorporate both payer and provider perspectives, the additions of Drs. Kansagra, Norrell, and Patterson reflect Precision AQ's commitment to evolving with the landscape. Precision AQ's AET boasts numerous oncology experts, including five Board Certified Oncology Pharmacists (BCOPs), from prominent payer and provider-based institutions across the United States. These new additions further bolster the AET's expertise and capabilities, including driving medical and pharmacy benefit management for Value Based Care, drug coverage policy and formulary design; optimizing patient care through quality improvement initiatives; and overseeing pharmacy and healthcare operations."We are delighted to welcome Shraddha, Angie, and Courtney to Precision AQ, bolstering our AET with additional expertise in oncology, one of the most innovative areas in healthcare," said Chad Clark, President and Chief Operating Officer of Precision Medicine Group. "Together with our existing roster of top-tier access decision makers, as well as our external network of over 100 oncology advisors from leading U.S

PR Newswire
Mar 31st, 2025
Precision Aq Earns Hitrust Implemented, 1-Year I1 Certification For Data Protection And Cybersecurity Risk Management

HITRUST i1 certification confirms Precision AQ's commitment to protecting sensitive data with leading security practices.NEW YORK, March 31, 2025 /PRNewswire/ -- Precision AQ, a leader in guiding life science organizations through the complexities of product commercialization and empowering access to life-changing medicines for all, announced today that its PatientLens platform has achieved HITRUST certification for system and information security.PatientLens transforms healthcare insights and patient program design by reducing friction in patient services and by delivering timely, actionable information to support decision-making. The platform offers a detailed view of insurance coverage, out-of-pocket costs, and medical or medication history. By leveraging tokenized patient data and advanced analytics, PatientLens helps healthcare organizations optimize patient outreach, prioritize cases, and ensure compliance, driving improved outcomes and operational efficiency.The HITRUST Implemented, 1-Year i1 validated assessment and certification process confirms that the PatientLens platform applies a robust set of HITRUST-curated controls. These controls ensure the organization follows leading security practices and maintains a comprehensive cybersecurity program to defend against cyber threats. HITRUST continuously analyzes cyber threat intelligence to keep its control requirements relevant, helping organizations mitigate emerging risks like phishing, brute force attacks, and ransomware, and supporting organizational resilience."The HITRUST i1 validated assessment is a powerful tool for cyber-aware organizations, such as Precision AQ," said Robert Booker, Chief Strategy Officer at HITRUST. "This certification assures the measurement, implementation, and performance of robust information security controls

GlobeNewswire
Mar 4th, 2025
Tenaya Therapeutics Announces Pricing of Public Offering

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a...